Skip to content

Inspection Record

FRUEH VERPACKUNGSTECHNIK AG — FDA 483 Findings

US FDAInspected 2023-03-24Published 2026-10-23 6 findingsMaterial and supplier controlQuality unit oversightEquipment and facilityOther quality systemDocumentation and records

Inspectors Stephen D. EichThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Material and supplier control

Requirements that must be met by suppliers have not been adequately established.

2Quality unit oversight

The responsibilities and procedures applicable to the quality unit are not in writing and fully followed.

3Equipment and facility

Procedures for the cleaning and maintenance of equipment are deficient regarding the protection of clean equipment from contamination prior to use.

4Other quality system

A process whose results cannot be fully verified by subsequent inspection and test has not been adequately validated.

5Documentation and records

The batch production and control records are deficient in that they do not include documentation of the accomplishment of each significant step in manufacturing, processing, and packing.

6Material and supplier control

Each lot in shipment received was not identified with a distinctive code for each container or grouping of containers for components, Specifically, The firm does not assign unique lot number for each lot in each shipment received for all drug components.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-23. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

FRUEH VERPACKUNGSTECHNIK AG company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.